Weight loss depends on duration of treatment, as well your personal commitment to diet an exercise in combination with treatment
And there is a point where we still have to connect with you over the phone or in person, but you can make that whatever you want too, because there are some people who are like, I just want to pick up my medications
Prescribers initiating BPC-157 in patients with Child-Pugh A or B hepatic impairment should document: (1) the clinical rationale for peptide therapy, (2) the absence of an FDA-approved alternative for the target condition, (3) baseline hepatic function with planned monitoring intervals, and (4) the patient's informed consent acknowledging the investigational nature of the therapy and the specific evidence limitations in their population
Pero son investigaciones preliminares que no prueban causa y efecto
Free Radical Biology and Medicine, 19 (2), 227250
McInnes, J